Improving nefiracetam dissolution and solubility behavior using a cocrystallization approach

19Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.

Abstract

In this work, we are the first to identify thirteen cocrystals of Nefiracetam, a poor water-soluble nootropic compound. Three of which were obtained with the biocompatible cocrystallization agents citric acid, oxalic acid, and zinc chloride. These latter have been fully structurally and physically characterized and the solubility, dissolution rate, and stability were compared to that of the initial Active Pharmaceutical Ingredient (API).

Cite

CITATION STYLE

APA

Buol, X., Robeyns, K., Garrido, C. C., Tumanov, N., Collard, L., Wouters, J., & Leyssens, T. (2020). Improving nefiracetam dissolution and solubility behavior using a cocrystallization approach. Pharmaceutics, 12(7), 1–14. https://doi.org/10.3390/pharmaceutics12070653

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free